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Abstract
Background: Commonly in surgical randomised controlled trials (RCT) the experimental treatment is a relatively
new technique which the surgeons may still be learning, while the control is a well-established standard. This can
lead to biased comparisons between treatments. In this paper we discuss the implementation of approaches for
addressing this issue in the ROLARR trial, and points of consideration for future surgical trials.
Methods: ROLARR was an international, randomised, parallel-group trial comparing robotic vs. laparoscopic surgery
for the curative treatment of rectal cancer. The primary endpoint was conversion to open surgery (binary). A
surgeon inclusion criterion mandating a minimum level of experience in each technique was incorporated.
Additionally, surgeon self-reported data were collected periodically throughout the trial to capture the level of
experience of every participating surgeon.
Multi-level logistic regression adjusting for operating surgeon as a random effect is used to estimate the odds ratio
for conversion to open surgery between the treatment groups. We present and contrast the results from the primary
analysis, which did not account for learning effects, and a sensitivity analysis which did.
Results: The primary analysis yields an estimated odds ratio (robotic/laparoscopic) of 0.614 (95% CI 0.311, 1.211; p = 0.16),
providing insufficient evidence to conclude superiority of robotic surgery compared to laparoscopic in terms of the risk of
conversion to open.
The sensitivity analysis reveals that while participating surgeons in ROLARR were expert at laparoscopic surgery, some, if
not all, were still learning robotic surgery. The treatment-effect odds ratio decreases by a factor of 0.341 (95% CI 0.121,
0.960; p = 0.042) per unit increase in log-number of previous robotic operations performed by the operating surgeon.
The odds ratio for a patient whose operating surgeon has the mean experience level in ROLARR – 152.46 previous
laparoscopic, 67.93 previous robotic operations – is 0.40 (95% CI 0.168, 0.953; p = 0.039).
Conclusions: In this paper we have demonstrated the implementation of approaches for accounting for learning in a
practical example of a surgery RCT analysis. The results demonstrate the value of implementing such approaches, since
we have shown that without them the ROLARR analysis would indeed have been confounded by the learning effects.
Trial registration: International Standard Randomised Controlled Trial Number (ISRCTN) registry, ID: ISRCTN80500123.
Registered on 27 May 2010.
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Background
Commonly in a surgical randomised controlled trial (RCT)
the experimental treatment is a relatively new technique
which the surgeons – both individually and as a community
– may still be learning, while the control treatment is a
well-established standard. One of the primary concerns
when designing and analysing a surgical RCT is that this
disparity between the levels of expertise that the participat-
ing surgeons have in each treatment may distort the com-
parison between the treatments, potentially leading to
biased treatment-effect estimates [1–4].
The need to account for learning effects in surgical
RCTs has long been recognised [1–4], and approaches
for minimising and accounting for the potentially con-
founding effects of learning have been developed in the
methodological literature [3]. However, there has been
limited uptake of these methods and few examples of
their application in surgical trial literature [5]. In this
paper we present the details of implementing these ap-
proaches in a practical example of a surgery RCT to
complement the more methodological papers such as
Ramsay and Cook’s [3]. Specifically, we demonstrate that
the results would have been vulnerable to the confound-
ing effects of learning if these methods were not imple-
mented, validating the concerns that motivated the
development of the methodology. We demonstrate the
value that these methods bring, and discuss points of
consideration for their use in future surgical trials.
The practical example is the Robotic vs. Laparoscopic
Resection for Rectal Cancer (ROLARR) trial, funded by
the National Institute of Health Research (NIHR) Effi-
cacy and Mechanism Evaluation Programme (EME)
programme. The aim of the trial was to compare the
safety, efficacy and short- and long-term outcomes of
robotic-assisted as compared to standard laparoscopic
rectal cancer surgery. In contrast to standard laparo-
scopic surgery, robotic-assisted surgery was not a
well-established approach at the beginning of the trial,
with many participating centres obtaining their first sur-
gical robot close to the time at which they began partici-
pating in the trial. This disparity only accentuated the
need to implement measures of estimating and adjusting
for the learning effects.
Methods
The ROLARR trial
ROLARR was an international, multicentre, randomised,
unblinded, parallel-group trial comparing robotic vs. lap-
aroscopic surgery for the curative treatment of rectal
cancer. The trial received national ethical approval in
the United Kingdom or either local Ethical Committee/
Institutional Review Board approval at international cen-
tres. An independent Trial Steering Committee and Data
Monitoring and Ethics Committee oversaw the trial
conduct. All participants provided written, informed
consent. The trial design has been reported previously
[6].
Consenting patients were randomised to receive either
laparoscopic mesorectal resection as per standard prac-
tice (referred to as ‘laparoscopic surgery’ hereafter) or
robotic-assisted laparoscopic mesorectal resection (re-
ferred to as ‘robotic surgery’ hereafter), which included
both totally robotic operations and hybrid operations in-
volving the use of standard laparoscopic techniques for
some aspects of the otherwise robotic-assisted operation.
Randomisation (minimisation incorporating a random
element) was on a 1:1 basis and was stratified by treating
surgeon and other selected prognostic patient factors
such as sex and Body Mass Index (BMI). This meant
that each participating surgeon in ROLARR was re-
quired to perform both robotic and laparoscopic surgery
on their trial patients.
The primary aim of the trial was to compare robotic
surgery to laparoscopic surgery for rectal cancer resec-
tion in terms of the technical difficulty of the operation.
The primary endpoint was intra-operative conversion to
open surgery, which is a binary indicator of technical
difficulty of the operation, and thus lower odds of con-
version to open would imply a less technically challen-
ging operation. A reduction of 50% to the odds of
conversion to open was considered to be the minimum
clinically important difference.
Design considerations for potential learning effects
In order to minimise confounding due to learning ef-
fects, a surgeon inclusion criterion mandating a mini-
mum level of experience in each technique was
included. The aim of this was to ensure that all partici-
pating surgeons were experts at both techniques, in the
sense that they would not still be in the process of learn-
ing either of the techniques while contributing to the
trial, ultimately leading to a fair comparison between
two expertly performed techniques at analysis. At the
design stage, the nature of the learning curve in robotic
surgery had relatively little evidence from which to de-
rive our inclusion criteria; the evidence base for laparo-
scopic learning curve was much stronger [7].
Furthermore, the feasibility of recruitment to the trial
had to be considered. As the mandated minimum level
of experience required increases, recruitment to the trial
becomes restricted to a smaller pool of surgeons. There-
fore, a pragmatic balance between minimising the
chances of learning effects via greater mandated mini-
mum surgeon experience and not compromising feasi-
bility of recruitment had to be found. Ultimately,
participating surgeons had to perform a minimum of 30
minimally invasive (laparoscopic or robotic) rectal can-
cer resections before taking part in the trial, of which at
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least 10 had to be laparoscopic and at least 10 robotic
resections.
In addition to this, data were collected periodically
throughout the trial to capture the level of experience of
every participating surgeon in performing each of the in-
terventions. All participating surgeons were asked to re-
port the number of previous laparoscopic operations
and the number of previous robotic operations that they
had performed prior to randomising their first patient.
Furthermore, throughout the recruitment period partici-
pating surgeons were asked at approximately 3-monthly
intervals to report how many laparoscopic and how
many robotic operations they had performed – including
operations performed outside of the ROLARR trial –
since their last reported figure. For each patient, the
level of experience of their operating surgeon at the time
of their operation was calculated assuming that the oper-
ation times within each interval between reported fig-
ures were uniform. For example, for a patient whose
operating surgeon had reported 98 laparoscopic opera-
tions and 56 robotic operations performed up to 30 June
2014, and a further three laparoscopic and one robotic
operations between 1 July 2014 and 30 September 2014,
and whose operation was on 24 September 2014 –
86 days into the 92-day interval between data captures
for their surgeon – the derived number of laparoscopic
operations performed by the operating surgeon at the
time of the operation was 98 + 3×(86/92) = 100.8, and
similarly for robotic, 56 + 1×(86/92) = 56.9.
Statistical analysis
The primary analysis included the use of multi-level lo-
gistic regression to estimate the odds ratios for conver-
sion to open surgery between the treatment groups
adjusting for the stratification factors as fixed effects, ex-
cept for operating surgeon which was adjusted for as a
random effect via a random intercept term.
The primary analysis did not include an adjustment
for the derived experience levels in laparoscopic and ro-
botic surgery of the operating surgeon at the time of op-
eration for each patient. The analysis of learning effects
extended the primary analysis model to include both
number of previous laparoscopic operations performed
and number of previous robotic operations performed
by the operating surgeon as main effects and also as in-
teractions with the treatment effect. Both a main effect
and an interaction effect with treatment for each of ro-
botic and laparoscopic learning was forced into the
model so that the effects of learning could be estimated
in each treatment arm separately. The main effects esti-
mate how learning affects outcomes in the laparoscopic
arm, while the interaction effects allow us to estimate
how learning affects outcomes in the robotic arm. To
parsimoniously account for the fact that the effect of
learning may be non-linear, fractional polynomials of de-
gree 1 were used to explore non-linear robotic and lap-
aroscopic effects by including power parameters for each
and selecting values for these parameters from a
pre-specified restricted space – {−2, −1, −0.5, 0, 0.5, 1, 2,
3} – which maximised the likelihood (minimised the de-
viance) of the model, as outlined by Royston and Altman
[8] and Royston and Sauerbrei [9]. Note that a power of
‘0’ in this context is defined as the natural log function.
The learning effects variables were also scaled and
centred at their mean values to improve the interpret-
ability of the corresponding regression coefficient esti-
mates. The Stata (v13) command fp was used, and the
selected fractional polynomial model was fitted in SAS
v9.4, for consistency with the primary analysis.
Both the primary analysis and the learning effects ana-
lysis were complete case analyses.
Missing data were minimal, and so sensitivity analyses
to quantify the potential impact of missing data on the
learning effects model were performed via brute-force
model re-fitting under a large number of potential values
of the missing fields.
Overly influential observations were identified for each
of the regression coefficients for treatment, laparoscopic
experience, robotic experience and the interaction terms
between treatment and laparoscopic and robotic experi-
ence in the learning effects analysis model via the deriv-
ation of exponentiated delta-betas. The exponentiated
delta-beta is calculated for each regression coefficient for
each patient, e.g. for patient i, the exponentiated
delta-beta for the treatment-effect regression coefficient
is:
exp β ið Þ1 −β1
 
¼
exp β ið Þ1
 
exp β1ð Þ
;
where β1 is the regression coefficient for the treatment
effect in the full model and βðiÞ1 is the treatment-effect
regression coefficient in the model where patient i has
been omitted. Note that this is the ratio of the estimated
odds ratios from the two models, e.g. an exponentiated
delta-beta for the treatment effect for patient i of 1.05
would imply that the omission of patient i increases the
treatment-effect odds ratio estimate by 5% compared to
the inclusion of patient i.
All analyses were pre-specified and were conducted on
the intention-to-treat (ITT) population, i.e. all rando-
mised patients were accounted for in the analyses, and
patients were categorised into treatment groups based
on their randomisation regardless of what they subse-
quently received. Estimates and their corresponding 95%
confidence intervals (CI) are presented. Analyses were
carried out in SAS v9.4 and Stata 13.
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Results
Figure 1 presents details on participant flow. A total of
471 patients were randomised, of which 466 (98.9%)
were included in the primary analysis; reasons for with-
drawals are given in Fig. 1. Four hundred and sixty-four
of the 466 patients from the primary analysis were in-
cluded in the learning effects analysis; two patients were
excluded due to missing experience data for their oper-
ating surgeons. The two treatment groups were well bal-
anced in terms of patient baseline characteristics
(Table 1).
The number of previous robotic and number of previ-
ous laparoscopic operations performed by the operating
surgeon at the time of operations was evaluated for each
patient (see ‘Methods’ section). The marginal summaries
of these measures over patients are presented in
Table 2 and the bivariate distribution of these mea-
sured over patients is visualised in a histogram in
Fig. 2. The average (median) patient in ROLARR re-
ceived an operation from a surgeon with experience
of 91.4 (interquartile range (IQR) 44.9, 180.1) previ-
ous laparoscopic and 49.5 (IQR 30.4, 101.3) previous
robotic rectal cancer operations. As seen in Fig. 2,
the large majority of operations were carried out by
an operating surgeon with experience lying within the
region bounded by 10–100 previous robotic and 10–
180 previous laparoscopic operations, with several
clusters of observations lying on the peripheries at
Fig. 1 Diagram showing the flow of participants
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high-robotic-low-laparoscopic and high-laparoscopic
regions. Conversions to open surgery were infrequent;
47/466 (10.1%) operations were converted to open,
28/230 (12.2%) in the laparoscopic group and 19/236
(8.1%) in the robotic group (Table 1). This made con-
versions to open surgery for patients whose operating
surgeon’s experience level was in these more periph-
eral regions capable of producing overly influential
observations in the learning effects analysis model.
Primary analysis (not adjusting for learning effects)
The primary analysis model yielded an adjusted odds ratio
of 0.614 (95% CI 0.311, 1.211; p = 0.16), suggesting that
the odds of conversion to open is reduced by around
38.6% (95% CI -21.1%, 68.9%) under robotic surgery com-
pared to laparoscopic. However, there is insufficient evi-
dence to conclude that robotic surgery reduces the odds
of conversion, since the confidence interval includes 1.
Learning effects analysis
Fractional polynomial fitting determined that the func-
tional forms for the robotic and laparoscopic learning ef-
fects in the model which best fitted the data were
natural log and cubed, respectively. The regression coef-
ficient estimates from the model resulting from adding
log robotic and cubic laparoscopic learning effects to the
primary analysis model (referred to hereafter as the
learning effects model) is presented in Table 3, and the
corresponding odds ratios are presented in Table 4.
The learning effects model yields an estimated odds
ratio for a patient whose operation is being performed
by a surgeon with the mean experience level in
ROLARR – 152.46 previous laparoscopic and 67.93 pre-
vious robotic operations performed – of 0.40 (95% CI
0.168, 0.953; p = 0.039).
Increasing operating surgeon laparoscopic and robotic
experience are estimated to have no notable effect on
the odds of conversion under laparoscopic surgery. This
is clear from the main effects estimates presented in
Table 3, which have negligible magnitude and
non-significant Wald tests. The effect of increasing oper-
ating surgeon laparoscopic experience is also estimated
to have no notable effect on the odds of conversion
under robotic surgery. This is reflected by the small ef-
fect size and non-significant Wald test for the inter-
action term for laparoscopic experience and treatment
in Table 3. However, the effect of increasing operating
surgeon robotic experience is clearly different under ro-
botic surgery compared to laparoscopic surgery. This is
clear from the significant Wald test for the interaction
term for robotic experience and treatment in Table 3.
The model suggests that the treatment-effect odds ratio
(robotic/laparoscopic) decreases by a factor of 0.341
(95% CI 0.121, 0.960; p = 0.042) per unit increase in
Table 1 Patient baseline characteristics and crude outcome data
Standard
laparoscopic
surgery (n = 234)
Robotic- assisted
laparoscopic surgery
(n = 237)
Total
(n = 471)
Gender
Male 159 (67.9%) 161 (67.9%) 320
(67.9%)
Female 75 (32.1%) 76 (32.1%) 151
(32.1%)
BMI classification
Underweight/
normal
87 (37.2%) 93 (39.2%) 180
(38.2%)
Overweight 92 (39.3%) 90 (38.0%) 182
(38.6%)
Obese 55 (23.5%) 54 (22.8%) 109
(23.2%)
Neo-adjuvant therapy
Yes 103 (44.0%) 109 (46.0%) 212
(45.0%)
No 131 (56.0%) 128 (54.0%) 259
(55.0%)
Intended procedure
High anterior
resection
34 (14.5%) 35 (14.8%) 69
(14.6%)
Low anterior
resection
158 (67.5%) 159 (67.1%) 317
(67.3%)
Abdominoperineal
resection
42 (17.9%) 43 (18.1%) 85
(18.0%)
Conversion to open surgery (outcome)
Yes 28 (12.2%) 19 (8.1%) 47
(10.1%)
No 202 (87.8%) 217 (91.9%) 419
(89.9%)
Missing 4 1 5
Percentages given are calculated using non-missing data only. Note that out
of the factors presented in this table, only ‘conversion to open surgery
(outcome)’ had missing data. BMI Body Mass Index
Table 2 Number of laparoscopic and robotic procedures
performed before the current operation, summarised across
patients
Number of. previous
laparoscopic procedures
performed by operating
surgeon
Number of previous
robotic procedures
performed by operating
surgeon
(n = 464) (n = 464)
Mean (SD) 152.5 (178.38) 67.9 (48.75)
Median (range) 91.4 (10.0, 853.0) 49.5 (10.3, 183.0)
Interquartile range (44.9, 180.1) (30.4, 101.3)
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log-number of previous robotic operations performed by
the operating surgeon.
Table 4 presents the estimated treatment-effect odds ra-
tio at various levels of operating surgeon laparoscopic and
robotic experience, and illustrates that increasing operat-
ing surgeon robotic experience notably affects the
treatment-effect odds ratio in favour of robotic surgery re-
gardless of the level of laparoscopic experience. Figure 3
presents the estimated treatment-effect odds ratios across
the entire range of robotic experience levels observed in
ROLARR while fixing laparoscopic experience at 91 (the
median). It shows a clear reduction in the odds ratio as ro-
botic experience increases. In particular, at levels of
robotic experience beyond 70 previous operations, the
model estimates clinically meaningful effect sizes (odds ra-
tios less than 0.5) which are statistically significant (confi-
dence intervals not spanning 1).
Furthermore, Fig. 4 presents the estimated
treatment-effect odds ratios across the entire range of ro-
botic experience levels at various selected levels of laparo-
scopic experience, and demonstrates that the relationship
seen in Fig. 3 holds regardless of laparoscopic experience
level. Figure 5 presents estimates of treatment-effects odds
ratios across a range of laparoscopic experience levels at
various selected levels of robotic experience, and demon-
strates that the estimated effect of laparoscopic experience
on the treatment effect is negligible.
Learning effects analysis: missing data
In order to test the robustness of the model against po-
tential effects of excluding the two patients with missing
data, sets of values of laparoscopic and robotic operating
surgeon experience were assumed for the two patients
and the model repeatedly re-fitted under various values.
In total this was done 625 times to cover all possible
combinations of number of previous laparoscopic opera-
tions in {10, 45, 91, 180, 500} and number of previous
robotic operations in {10, 30, 50, 101, 183} for each pa-
tient. None of the re-fitted models yielded estimates that
were notably different to the model which excluded
these two patients. The distributions of estimates from
these 625 models are summarised in Table 5.
Learning effects analysis: highly influential observations
To explore whether the learning effects analysis model
results were being disproportionately determined by
Fig. 2 Histogram of the bivariate distribution of number of laparoscopic and robotic procedures performed before the current operation (viewed
from two different angles)
Table 3 Estimated regression coefficients (log-odds ratios), 95%
confidence intervals and Wald test p values for the treatment
and learning effects from the primary analysis and learning
effects models
Model Effect Adjusted
estimate
95% confidence
interval for
adjusted estimate
p
Lower Upper
Primary
analysis
model
Robotic surgery
(vs. laparoscopic)
− 0.488 − 1.168 0.191 0.158
Learning
effects
model
Robotic surgery
(vs. laparoscopic)
− 0.916 − 1.784 −
0.049
0.039
Surgeon’s robotic
experience
(log; 1-unit increase)
0.074 − 0.706 0.854 0.852
Surgeon’s laparoscopic
experience
(cubic; 10^8-unit increase)
0.309 −
1.1033
0.4852 0.445
Interaction: surgeon’s
robotic experience
(log; 1-unit increase)
× robotic surgery
− 1.076 − 2.110 −
0.041
0.042
Interaction: surgeon’s
laparoscopic experience
(cubic; 10^8-unit increase)
× robotic surgery
− 0.160 − 2.153 1.833 0.875
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overly influential observations from regions of sparse
data, the exponentiated delta-betas for the treatment ef-
fect, main effects of laparoscopic and robotic experience,
and interactions between treatment effect and lap-
aroscopic and robotic experience were calculated.
Several overly influential observations were identi-
fied. For example, the most influential observation
on the robotic experience by treatment-effect inter-
action term had an exponentiated delta-beta of
0.730. When the model was fitted omitting that pa-
tient, it estimated that the treatment-effects odds ra-
tio (robotic/laparoscopic) decreases by a factor of
0.249 (95% CI 0.080, 0.773; p = 0.0163) per unit in-
crease in log-number of previous robotic operations
performed by the operating surgeon, rather than the
factor of 0.341 (95% CI 0.121, 0.960; p = 0.042) re-
ported above. That patient was operated on by a sur-
geon with 169.6 previous robotic and 21.02 previous
laparoscopic operations – in a peripheral area of ex-
perience with sparse data (see Fig. 2) – and was the
only conversion to open surgery out of the 49 pa-
tients operated on by two surgeons who lie in that
region. All of the overly influential observations were
similar to this example: legitimate observations, con-
versions to open and with operating surgeon experi-
ence towards the extremities of the observed
distribution, in areas of relatively sparse data.
A concern which naturally develops from that is
that if the model estimates are being highly influ-
enced by data in the extremities of the distribution of
Table 4 Estimated adjusted odds ratios (robotic vs. laparoscopic) for conversion to open surgery vs. operating surgeon’s level of
previous laparoscopic and robotic experience
Effect Surgeon’s
laparoscopic
experience level
(no. of previous
operations)
Surgeon’s robotic
experience level
(no. of previous
operations)
Adjusted odds
ratio (robotic vs.
laparoscopic)
95% confidence interval for adjusted odds ratio
Lower limit Upper limit
Primary analysis model
Robotic surgery (vs. laparoscopic)
– – 0.614 0.311 1.211
Learning effects model
Robotic surgery (vs. laparoscopic)
45 30 0.969 0.431 2.178
50 0.559 0.264 1.185
100 0.265 0.084 0.840
91 30 0.968 0.432 2.172
50 0.559 0.265 1.180
100 0.265 0.084 0.836
180 30 0.960 0.431 2.138
50 0.554 0.267 1.151
100 0.263 0.085 0.814
Fig. 3 Graph of estimated odds ratio (robotic vs. laparoscopic) and 95% confidence interval for conversion to open surgery vs. operating surgeon
previous robotic experience at the median level of laparoscopic experience
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experience levels, then the model may not be an ac-
curate representation of the majority of ROLARR par-
ticipants. Thus, in order to explore the robustness of
model estimates, the model was fitted again including
only patients whose operation was performed by a
surgeon whose laparoscopic and robotic experience
levels were lower than the upper quartiles – i.e. between
10 and 101.3 previous robotic and between 10 and 180.1
previous laparoscopic operations. This limited model
yielded very similar estimates. The estimated relationships
of robotic experience vs. treatment effect and laparoscopic
experience vs. treatment effect from this re-fitted model
Fig. 4 Panel plot of estimated odds ratio (robotic vs. laparoscopic) and 95% confidence interval for conversion to open surgery vs. operating
surgeon previous robotic experience at various levels of laparoscopic experience
Fig. 5 Panel plot of estimated odds ratio (robotic vs. laparoscopic) and 95% confidence interval for conversion to open surgery vs. operating
surgeon previous laparoscopic experience at various levels of robotic experience
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are presented in Figs. 6 and 7, and are clearly very
similar to the relationships seen from the full model
in Figs. 4 and 5.
Discussion
The primary analysis for ROLARR provided insufficient
evidence of superiority of robotic surgery. The estimated
odds ratio did not show a clinically important reduction
in the odds of conversion to open under robotic surgery
compared to laparoscopic. In isolation, the primary
analysis suggests that robotic surgery, as compared with
laparoscopic surgery, does not significantly reduce the
risk of conversion to open surgery when performed by
surgeons with varying experience of robotic surgery.
The results of the learning effects analysis suggest that
participating surgeons in ROLARR were already experts
in laparoscopic surgery with respect to the need to con-
vert to open surgery. This is clear from the negligible
estimated effect of increasing operating surgeon laparo-
scopic surgery experience on both the conversion rate in
Table 5 Summary of regression coefficients and standard errors produced by the 625 models which incorporated a range of
imputed operating experience data for the two patients who had missing data (see ‘Methods’ section)
Parameter Original learning effects
model parameter estimate
Median and range of parameter
estimates from the 625 models
of imputed data
Treatment effect: estimate − 0.916 − 0.946 (− 0.964, − 0.908)
Treatment effect: standard error 0.441 0.441 (0.438, 0.443)
Laparoscopic experience: estimate − 0.309 − 0.317 (− 0.338, − 0.205)
Laparoscopic experience: standard error 0.404 0.408 (0.349, 0.409)
Robotic experience: estimate 0.074 0.073 (− 0.080, 0.168)
Robotic experience: standard error 0.397 0.392 (0.382, 0.397)
Treatment × laparoscopic experience interaction: estimate − 0.160 − 0.144 (− 0.226, − 0.135)
Treatment × laparoscopic experience interaction: standard error 1.014 1.012 (0.989, 1.015)
Treatment × robotic experience interaction: estimate − 1.076 − 1.077 (− 1.149, − 0.970)
Treatment × robotic experience interaction: standard error 0.526 0.524 (0.518, 0.527)
Fig. 6 Panel plot of estimated odds ratio (robotic vs. laparoscopic) and 95% confidence interval for conversion to open surgery vs. operating
surgeon previous robotic experience at various levels of laparoscopic experience (fitted on subsample of patients). This model was only fitted on
patients whose operating surgeon had <= 101.3 previous robotic operations and <=180.1 previous laparoscopic operations. The graphs have
been split by colour to show the model estimates where the actual data is and the model estimates which are extrapolations
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the laparoscopic arm and on the difference between
arms, adjusting for prognostic patient factors as well as
other operating surgeon factors (caught by adjusting for
operating surgeon as a random effect). However, it
seems that the surgeon inclusion criterion did not fully
accomplish the aim of ensuring that all participating sur-
geons were experts in both treatments, since the results
also suggest that some, if not all, participating surgeons
in ROLARR were still learning robotic surgery. This is
clear from the notable effect of increasing operating sur-
geon robotic surgery experience on both the conversion
rate in the robotic arm and on the difference between
arms, again adjusting for prognostic patient factors as
well as other operating surgeon factors (caught by
adjusting for operating surgeon as a random effect).
Furthermore, the nature of the relationship between
operating surgeon robotic experience and the treatment
effect suggest that the desired clinically important differ-
ence between the treatments occurs at higher levels of
robotic surgery experience than the average (median) in
ROLARR. Given this, it could be argued that the pri-
mary analysis represents a comparison of laparoscopic
surgery and robotic surgery when performed by a sur-
geon who is an expert at laparoscopic surgery, but still
learning robotic surgery. While this may be representa-
tive of clinical practice during the period over which
ROLARR took place, it could be argued that it does not
tell us the whole story for the purpose of policy-making.
The learning effects analysis paints a clear picture,
suggesting that robotic surgery does in fact confer an ad-
vantage compared to laparoscopic surgery in terms of
the risk of converting to open surgery when the operat-
ing surgeon has more substantial previous experience
with robotic surgery. Model diagnostics and sensitivity
analyses for the learning effects model have shown it to
be a significantly better fit than the primary analysis
model, and have also shown it to be robust to the poten-
tial effects of the two excluded patients and to the ef-
fects of highly influential observations.
Limitations
One limitation of the learning effects analysis in
ROLARR is that the experience variables were fitted
as fixed effects in the model. This imposes the impli-
cit assumption that every surgeon has exactly the
same learning curve. This may be an overly strong
assumption and it may be more appropriate to in-
clude random effects for the experience variables –
both their main effects and their interactions – which
in particular would allow for the possibility that dif-
ferent surgeons learn at different rates and plateau at
different levels of proficiency. In this particular case,
attempting the inclusion of random effects led to
model convergence issues.
Another limitation is that the presented learning effects
model only accounts for learning on an individual level,
Fig. 7 Panel plot of estimated odds ratio (robotic vs. laparoscopic) and 95% confidence interval for conversion to open surgery vs. operating
surgeon previous laparoscopic experience at various levels of robotic experience (fitted on subsample of patients). This model was only fitted on
patients whose operating surgeon had <= 101.3 previous robotic operations and <=180.1 previous laparoscopic operations. The graphs have
been split by colour to show the model estimates where the actual data is and the model estimates which are extrapolations
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derived only from the number of previous operations
performed, and assumes that proficiency is monotonic
non-decreasing. The former is a simplification of a com-
plex mechanism by which an individual surgeon’s profi-
ciency is affected via multiple sources including learning
at an expert community level as well as from sheer case
volume [4, 10, 11], e.g. a surgeon with 30 operations
spread out over 3 years is perhaps not going to be as
proficient as a surgeon with 30 cases performed over
3 months, all else being equal. The latter is a simplifica-
tion of the nature of learning, which can involve deterio-
rations in proficiency; e.g. due to length of time since
the most recent operation [10]; e.g. a surgeon with 100
previous cases, but who has not performed a case in
over 5 years, may be expected to be less proficient than
a surgeon with 100 previous cases all performed within
the last year, all else being equal.
Conclusions
The learning effects analysis presented suggests, in con-
trast to the primary analysis, that robotic-assisted
laparoscopic surgery does confer an advantage over
standard laparoscopic surgery in terms of the risk of
conversion to open surgery, when performed by an oper-
ating surgeon with a substantial level of previous experi-
ence with robotic surgery, regardless of their level of
previous experience in standard laparoscopic surgery.
Beyond the ROLARR trial, in this paper we have dem-
onstrated the implementation of these approaches for
accounting for learning in a practical example of a
surgery RCT analysis which would otherwise have been
vulnerable to the confounding effects of learning. The
results demonstrate the value of implementing such
approaches since we can see that without them the
analysis would indeed have been confounded.
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